AED maker announces preliminary second-quarter revenue results.

2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Cardiac Science, Inc., (DFIB) announced revenue for its second quarter ended June 30, 2004 was within the range of company guidance and is expected to be between $17.3-17.5 million, representing sequential growth of approximately 11% over the first quarter ended March 31, 2004 and approximately 20% over last year's second quarter.

Cardiac Science Chairman and CEO Raymond W. Cohen said, "We are pleased with the top line results for the period, which are within the range we had estimated. This is especially true in light of the fact that our two new AED (automated external defibrillator) products, the …